Published: 2021 Aug 28; Revised: 2021 Sep 3; Issue date: 2022 Feb.
This article is available under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. It allows for the use and distribution of the original work in any medium, provided proper citation is given, and it is not used for commercial purposes or modified.
New Subtitle 1
Diabetes mellitus (DM) is a chronic metabolic disorder characterized by high blood sugar levels and is one of the most common chronic illnesses. The prevalence of DM has increased over time, leading to serious health complications. These include macroangiopathy, microangiopathy, neuropathy, and sexual dysfunction. Erectile dysfunction (ED) is a significant issue in men with DM, with a prevalence around 3.5 times higher compared to men without DM. Lifestyle factors such as inactivity, excess weight, and high calorie intake contribute to the development of DM and its complications. Targeted treatments may be required to improve sexual function. This study aims to examine the definition and prevalence of ED in DM, the impact of DM on ED, and current and emerging therapies for ED in DM patients.
Keywords: diabetes, diabetes complications, diabetes treatment, erectile dysfunction, hypogonadism, PDE5 inhibitors
New Subtitle 2
The incidence of ED is estimated to be 25–30 cases per thousand person-years, with about 20%–30% of adult men experiencing at least one sexual dysfunction issue. Age is a significant risk factor for sexual dysfunction, with prevalence increasing with age, especially in older men.
Men with DM are at higher risk for ED. Research shows varying rates of ED in men with DM, depending on the type and duration of DM, treatment, and other health conditions. Overall, individuals with DM are approximately 3.5 times more likely to experience ED than those without DM.
In addition to age and diabetes, other risk factors for ED include obesity, smoking, high blood pressure, and cardiovascular disease. Psychological factors such as stress, anxiety, and depression can also contribute to the development of ED. It is important for men experiencing ED to seek medical advice and consider lifestyle changes and treatments to improve their condition.
The link between diabetes and erectile dysfunction (ED) is a complex interplay of various factors, including age, dyslipidemia, high blood pressure, heart disease, obesity, lack of physical activity, and smoking. These factors affect blood vessel function, testosterone levels, nervous system influences, and psychological components, all contributing to ED. In diabetes, high blood sugar levels lead to increased oxidative stress, affecting nitric oxide production and causing inflammation, which further exacerbates ED.
Early detection of ED in diabetes patients is crucial for better management of diabetic complications. Complications related to diabetes, such as diabetic nephropathy, cardiovascular disease, hypogonadism, obstructive sleep apnoea syndrome, and depression, all play a role in the development of ED.
Various medications, such as metformin, pioglitazone, SGLT2 inhibitors, and PDE5 inhibitors, have been studied for their effects on ED in diabetes patients. Metformin has shown positive outcomes on endothelium-dependent vasodilation, while pioglitazone has demonstrated benefits on improving veno-occlusive dysfunction. SGLT2 inhibitors offer cardiorenal advantages and have shown improvements in erectile function in diabetic patients. PDE5 inhibitors, including sildenafil, vardenafil, and tadalafil, remain the primary therapy for ED, with different formulations and dosing regimens available for diabetic patients.
Lifestyle adjustments, weight management, physical activity, and glycemic control are recommended to address ED in diabetes. Surgery and hormone replacement therapy may be necessary for severe cases of ED. Overall, a comprehensive approach that includes addressing diabetes-related complications and using appropriate medications can help manage ED in diabetic patients effectively.